BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30760710)

  • 1. Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.
    Mieszczanek J; van Tienen LM; Ibrahim AEK; Winton DJ; Bienz M
    Nat Commun; 2019 Feb; 10(1):724. PubMed ID: 30760710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer.
    Gay DM; Ridgway RA; Müller M; Hodder MC; Hedley A; Clark W; Leach JD; Jackstadt R; Nixon C; Huels DJ; Campbell AD; Bird TG; Sansom OJ
    Nat Commun; 2019 Feb; 10(1):723. PubMed ID: 30760720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.
    Talla SB; Brembeck FH
    Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe polyposis in Apc(1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5.
    Lewis A; Segditsas S; Deheragoda M; Pollard P; Jeffery R; Nye E; Lockstone H; Davis H; Clark S; Stamp G; Poulsom R; Wright N; Tomlinson I
    Gut; 2010 Dec; 59(12):1680-6. PubMed ID: 20926645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminus of Apc does not influence intestinal adenoma development or progression.
    Lewis A; Davis H; Deheragoda M; Pollard P; Nye E; Jeffery R; Segditsas S; East P; Poulsom R; Stamp G; Wright N; Tomlinson I
    J Pathol; 2012 Jan; 226(1):73-83. PubMed ID: 22009253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
    Wielenga VJ; Smits R; Korinek V; Smit L; Kielman M; Fodde R; Clevers H; Pals ST
    Am J Pathol; 1999 Feb; 154(2):515-23. PubMed ID: 10027409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
    Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
    PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the interaction between BCL9-Pygo and LDB-SSBP complexes in assembling the Wnt enhanceosome.
    Wang H; Bienz M; Yan XX; Xu W
    Nat Commun; 2023 Jun; 14(1):3702. PubMed ID: 37349336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploinsufficiency of Casitas B-Lineage Lymphoma Augments the Progression of Colon Cancer in the Background of Adenomatous Polyposis Coli Inactivation.
    Richards S; Walker J; Nakanishi M; Belghasem M; Lyle C; Arinze N; Napoleon MA; Ravid JD; Crossland N; Zhao Q; Rosenberg D; Rahimi N; Chitalia VC
    Am J Pathol; 2020 Mar; 190(3):602-613. PubMed ID: 32113662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cited1 deficiency suppresses intestinal tumorigenesis.
    Méniel V; Song F; Phesse T; Young M; Poetz O; Parry L; Jenkins JR; Williams GT; Dunwoodie SL; Watson A; Clarke AR
    PLoS Genet; 2013; 9(8):e1003638. PubMed ID: 23935526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling.
    Bonnans C; Flacelière M; Grillet F; Dantec C; Desvignes JP; Pannequin J; Severac D; Dubois E; Bibeau F; Escriou V; Crespy P; Journot L; Hollande F; Joubert D
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3047-52. PubMed ID: 22315403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tensin4 (TNS4) is upregulated by Wnt signalling in adenomas in multiple intestinal neoplasia (Min) mice.
    Raposo TP; Alfahed A; Nateri AS; Ilyas M
    Int J Exp Pathol; 2020 Jun; 101(3-4):80-86. PubMed ID: 32567731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for the tissue specificity of β-catenin oncogenesis.
    Sharma A; Sen JM
    Oncogene; 2013 Apr; 32(15):1901-9. PubMed ID: 22689057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
    Jaeckel S; Kaller M; Jackstadt R; Götz U; Müller S; Boos S; Horst D; Jung P; Hermeking H
    Nat Commun; 2018 Sep; 9(1):3573. PubMed ID: 30177706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
    Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
    Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
    Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
    Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.